TokenPost·
uniQure Says FDA Grants Priority Review to Huntington’s Gene Therapy
The application seeks accelerated approval, and the company plans to begin U.S. screening for a 200-patient confirmatory trial by the end of 2026.
More news
- Crypto BriefingSBI plans $100 million investment in US digital bank Erebor to explore blockchain settlements
- TokenPostSpace Reconnaissance Orders at Syntec Optics Climb Nearly 25%
- TokenPostChangpeng Zhao Warns Binance Users About Post-Breach Recovery Scams
- BeInCrypto$106 Million Crypto Theft Hits EU Entity With Multiple Exchange Accounts
- TokenPostFluence Energy Names Board Member Axel Meier Interim CEO
- TokenPostVanguard Ultra-Short Treasury ETF Sets $0.2442 Monthly Dividend